Portfolio comparison
Immatics Biotechnologies vs 8 Rivers Capital
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
Company B
8 Rivers Capital
Patents indexed
1
energymaterialsenvironmentalchemicalindustrial_manufacturing
Top Patents1 enriched
US 20220203297
Capturing Carbon Dioxide While Making Industrial Materials
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.